124 related articles for article (PubMed ID: 31368109)
21. Aldehyde dehydrogenase 2 deficiency promotes skeletal muscle atrophy in aged mice.
Kasai A; Jee E; Tamura Y; Kouzaki K; Kotani T; Nakazato K
Am J Physiol Regul Integr Comp Physiol; 2022 Jun; 322(6):R511-R525. PubMed ID: 35318866
[TBL] [Abstract][Full Text] [Related]
22. Mitochondrial aldehyde dehydrogenase 2 deficiency aggravates energy metabolism disturbance and diastolic dysfunction in diabetic mice.
Wang C; Fan F; Cao Q; Shen C; Zhu H; Wang P; Zhao X; Sun X; Dong Z; Ma X; Liu X; Han S; Wu C; Zou Y; Hu K; Ge J; Sun A
J Mol Med (Berl); 2016 Nov; 94(11):1229-1240. PubMed ID: 27488451
[TBL] [Abstract][Full Text] [Related]
23. Aldehyde dehydrogenase 2 in aplastic anemia, Fanconi anemia and hematopoietic stem cells.
Van Wassenhove LD; Mochly-Rosen D; Weinberg KI
Mol Genet Metab; 2016 Sep; 119(1-2):28-36. PubMed ID: 27650066
[TBL] [Abstract][Full Text] [Related]
24. ALDH2---The Genetic Polymorphism and Enzymatic Activity Regulation: Their Epidemiologic and Clinical Implications.
Zhang R; Wang J; Xue M; Xu F; Chen Y
Curr Drug Targets; 2017; 18(15):1810-1816. PubMed ID: 26212265
[TBL] [Abstract][Full Text] [Related]
25. Aldehyde Dehydrogenases Genetic Polymorphism and Obesity: From Genomics to Behavior and Health.
Hu C
Adv Exp Med Biol; 2019; 1193():135-154. PubMed ID: 31368102
[TBL] [Abstract][Full Text] [Related]
26. Targeting acetaldehyde dehydrogenase 2 (ALDH2) in heart failure-Recent insights and perspectives.
Pang J; Wang J; Zhang Y; Xu F; Chen Y
Biochim Biophys Acta Mol Basis Dis; 2017 Aug; 1863(8):1933-1941. PubMed ID: 27742538
[TBL] [Abstract][Full Text] [Related]
27. Homozygous ALDH2*2 Is an Independent Risk Factor for Ischemic Stroke in Taiwanese Men.
Sung YF; Lu CC; Lee JT; Hung YJ; Hu CJ; Jeng JS; Chiou HY; Peng GS
Stroke; 2016 Sep; 47(9):2174-9. PubMed ID: 27486170
[TBL] [Abstract][Full Text] [Related]
28. Role of aldehyde dehydrogenase 2 in ischemia reperfusion injury: An update.
Panisello-Roselló A; Lopez A; Folch-Puy E; Carbonell T; Rolo A; Palmeira C; Adam R; Net M; Roselló-Catafau J
World J Gastroenterol; 2018 Jul; 24(27):2984-2994. PubMed ID: 30038465
[TBL] [Abstract][Full Text] [Related]
29. Aberrant reactive aldehyde detoxification by aldehyde dehydrogenase-2 influences endometriosis development and pain-associated behaviors.
McAllister SL; Sinharoy P; Vasu M; Gross ER
Pain; 2021 Jan; 162(1):71-83. PubMed ID: 32541390
[TBL] [Abstract][Full Text] [Related]
30. Identification of three novel loci of ALDH2 Gene for Serum Folate levels in a Male Chinese Population by Genome-Wide Association Study.
Deng C; Tang S; Huang X; Gao J; Tian J; Zhou X; Xie Y; Liao M; Mo Z; Wang Q
Gene; 2018 Oct; 674():121-126. PubMed ID: 29953918
[TBL] [Abstract][Full Text] [Related]
31. Aldehyde Dehydrogenase-2 Roles in Ischemic Cardiovascular Disease.
Liu X; Sun A
Curr Drug Targets; 2017; 18(15):1817-1823. PubMed ID: 27633387
[TBL] [Abstract][Full Text] [Related]
32. Targeting aldehyde dehydrogenase 2: new therapeutic opportunities.
Chen CH; Ferreira JC; Gross ER; Mochly-Rosen D
Physiol Rev; 2014 Jan; 94(1):1-34. PubMed ID: 24382882
[TBL] [Abstract][Full Text] [Related]
33. Aldehyde dehydrogenase 2 activation and coevolution of its εPKC-mediated phosphorylation sites.
Nene A; Chen CH; Disatnik MH; Cruz L; Mochly-Rosen D
J Biomed Sci; 2017 Jan; 24(1):3. PubMed ID: 28056995
[TBL] [Abstract][Full Text] [Related]
34. ULK1-regulated autophagy: A mechanism in cellular protection for ALDH2 against hyperglycemia.
Liu M; Lu S; He W; Zhang L; Ma Y; Lv P; Ma M; Yu W; Wang J; Zhang M; Zhang Y; Li Y
Toxicol Lett; 2018 Feb; 283():106-115. PubMed ID: 29128638
[TBL] [Abstract][Full Text] [Related]
35. Mitochondrial Aldehyde Dehydrogenase in Myocardial Ischemic and Ischemia-Reperfusion Injury.
Ding J; Yang Z; Ma H; Zhang H
Adv Exp Med Biol; 2019; 1193():107-120. PubMed ID: 31368100
[TBL] [Abstract][Full Text] [Related]
36. Mitochondrial Aldehyde Dehydrogenase 2 Regulates Revascularization in Chronic Ischemia: Potential Impact on the Development of Coronary Collateral Circulation.
Liu X; Sun X; Liao H; Dong Z; Zhao J; Zhu H; Wang P; Shen L; Xu L; Ma X; Shen C; Fan F; Wang C; Hu K; Zou Y; Ge J; Ren J; Sun A
Arterioscler Thromb Vasc Biol; 2015 Oct; 35(10):2196-206. PubMed ID: 26315408
[TBL] [Abstract][Full Text] [Related]
37. Baicalin protects H9c2 cardiomyocytes against hypoxia/reoxygenation-induced apoptosis and oxidative stress through activation of mitochondrial aldehyde dehydrogenase 2.
Jiang WB; Zhao W; Chen H; Wu YY; Wang Y; Fu GS; Yang XJ
Clin Exp Pharmacol Physiol; 2018 Mar; 45(3):303-311. PubMed ID: 29047162
[TBL] [Abstract][Full Text] [Related]
38. Targeting ALDH2 for Therapeutic Interventions in Chronic Pain-Related Myocardial Ischemic Susceptibility.
Li C; Sun W; Gu C; Yang Z; Quan N; Yang J; Shi Z; Yu L; Ma H
Theranostics; 2018; 8(4):1027-1041. PubMed ID: 29463997
[TBL] [Abstract][Full Text] [Related]
39. Impaired ALDH2 activity decreases the mitochondrial respiration in H9C2 cardiomyocytes.
Mali VR; Deshpande M; Pan G; Thandavarayan RA; Palaniyandi SS
Cell Signal; 2016 Feb; 28(2):1-6. PubMed ID: 26577527
[TBL] [Abstract][Full Text] [Related]
40. Alda-1, an ALDH2 activator, protects against hepatic ischemia/reperfusion injury in rats via inhibition of oxidative stress.
Zhang T; Zhao Q; Ye F; Huang CY; Chen WM; Huang WQ
Free Radic Res; 2018 Jun; 52(6):629-638. PubMed ID: 29589772
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
